Personal experience + peer-reviewed information about Babesia and tick-associated infections.
Real Answers. Real Recovery.
Beat Babesia mark Beat BabesiaPersonal experience • research • resources
JUST GOT BIT BY A TICK? START HERE NOW →
What helped me #2

Cryptolepis

Cryptolepis became one of the three things I most associate with improvement in my own Babesia experience. Unlike a lot of alternative-treatment claims online, there is actually Babesia-specific peer-reviewed research here. It is still preclinical—but it gives us concrete reasons researchers think this plant and its alkaloid cryptolepine deserve attention.

By Phil Iavarone • Personal experience & independent research • Sources last checked August 25, 2026
Herbal tincture, notebook, and laboratory glassware
My experience

Why Cryptolepis became part of my story

After going through prescription treatment and still dealing with a cycle of improvement and returning symptoms, I kept looking. Cryptolepis was one of the herbal approaches that became important in that search.

Along with ozone and artemisinin, it is one of the things I most associate with progress in my own experience.

My personal schedule was one full dropper of Cryptolepis plus two artemisinin capsules each day for three days, followed by four days off. I am sharing that only as a record of what I did—not as a dosing recommendation. Tincture concentrations, dropper sizes and artemisinin strengths can vary substantially between products.

The evidence line

The evidence is real—and still preclinical.

Cryptolepis has not been proven in a randomized human babesiosis trial. But the evidence is considerably more specific than “an herb that might help”: researchers have tested Cryptolepis sanguinolenta or its major alkaloid cryptolepine directly against multiple Babesia species in laboratory systems, and cryptolepine has also been studied in a mouse B. microti model.

That evidence is biologically relevant and peer-reviewed, but it remains preclinical and is not proof of human clinical effectiveness.

Babesia-specific peer-reviewed research

Why Cryptolepis could plausibly have anti-Babesia activity

These studies do not prove that a Cryptolepis supplement cures human babesiosis. They do show that the plant and its active alkaloid are not being discussed in a scientific vacuum.

2021 • B. duncani in vitro

Cryptolepis extract and cryptolepine inhibited Babesia duncani

A study published in Frontiers in Cellular and Infection Microbiology screened botanical medicines against B. duncani. Cryptolepis sanguinolenta showed strong inhibitory activity in the laboratory model, and its alkaloid cryptolepine had an IC50 of about 3.4 μM.

The researchers also performed regrowth experiments. After sufficiently high exposure, cryptolepine-treated parasites and cultures treated with the 90% ethanol Cryptolepis extract failed to regrow under the reported subculture conditions.

Why that matters: this is direct testing against a human-pathogenic Babesia species—not simply an extrapolation from another infection.

Limitation: it was an in-vitro model. Concentrations that inhibit parasites in a dish do not tell us what oral dosing achieves in human blood or whether clinical outcomes improve.

Zhang et al., 2021 — Botanical Medicines ... Demonstrate Inhibitory Activity Against Babesia duncani

2020 • Multiple Babesia species + mice

Cryptolepine inhibited several Babesia species and reduced B. microti growth in mice

A 2020 paper in PLOS Neglected Tropical Diseases tested cryptolepine against B. bovis, B. bigemina, B. divergens, and B. caballi in vitro. The compound inhibited growth of all four species in a dose-dependent manner.

The same paper moved beyond the petri dish: in a mouse model, cryptolepine at the tested dose inhibited multiplication of B. microti. Combinations with atovaquone or diminazene produced stronger effects than cryptolepine alone in that experimental model.

Why that matters: it provides both cross-species Babesia activity and an in-vivo signal in an organism—not just a cell-culture result.

Limitation: a mouse experiment is not a human clinical trial, and the paper studied isolated cryptolepine rather than proving the effectiveness or dose of a commercial whole-plant supplement.

Batiha et al., 2020 — In vitro and in vivo growth inhibitory activities of cryptolepine hydrate against several Babesia species

Mechanistic clues

What might cryptolepine be doing?

The Babesia papers show growth inhibition, but the exact molecular target in Babesia has not been nailed down. Research in related protozoa gives several plausible mechanisms researchers can investigate.

Related blood parasite

Strong antiplasmodial activity

Plasmodium, the malaria parasite, is another intraerythrocytic apicomplexan. Peer-reviewed studies have shown strong cryptolepine activity against both chloroquine-sensitive and resistant P. falciparum strains, with activity also demonstrated in rodent malaria models.

Why that could matter: activity across related red-blood-cell parasites makes a genuine antiprotozoal mechanism more plausible than a nonspecific wellness effect.

Cimanga et al., 1997 • Kirby et al., 2000

DNA / topoisomerase

Cryptolepine can interact with DNA and topoisomerase II

Laboratory studies have shown that cryptolepine can intercalate into DNA and stabilize topoisomerase-II/DNA cleavage complexes. That has been proposed as one possible basis for some of its antiparasitic and cytotoxic effects.

Why that could matter: disrupting parasite DNA replication or processing is a plausible antiparasitic route.

Why caution matters too: DNA interaction is also one reason researchers pay attention to toxicity and selectivity. A mechanism that can hurt a parasite is not automatically harmless to human cells.

Bonjean et al., 1998/1999 — topoisomerase II/DNA study

Quinoline-like effects

Other research suggests more than one possible target

Structure-activity work on cryptolepine analogues has also suggested chloroquine-like / heme-related mechanisms in malaria parasites, including inhibition of β-hematin formation. That means the compound's antiprotozoal action may not depend on a single pathway.

Why that could matter: multi-target activity could help explain why cryptolepine shows effects across several protozoan species—but the mechanism in Babesia remains to be determined directly.

Wright et al., 2001 — cryptolepine analogue mechanistic study

What I think is fair to say

The evidence is promising enough to discuss—without overselling it.

  • Fair: Cryptolepis was one of the things I personally felt helped me.
  • Fair: Cryptolepis sanguinolenta extract and cryptolepine have inhibited B. duncani in vitro.
  • Fair: cryptolepine has inhibited several other Babesia species in vitro and reduced B. microti growth in a mouse model.
  • Fair: research in related protozoa provides plausible molecular mechanisms for antiparasitic activity.
  • Not fair: saying that a Cryptolepis tincture is clinically proven to cure human babesiosis or assuming a laboratory concentration translates directly into an oral dose.
My bottom line: Cryptolepis has enough Babesia-specific peer-reviewed evidence that I think it deserves serious research attention. I can say that while still being completely honest that we need controlled human studies before anybody can call it a proven babesiosis treatment.
Related reading

Keep going

Products from my personal experience • affiliate links

Cryptolepis & artemisinin

These are the Amazon-linked products connected to what I personally used. I am sharing them as part of my experience, not as proven babesiosis treatments or dosing recommendations. Browse all recommended products →

Cryptolepis sanguinolentaWhat I personally used

Cryptolepis sanguinolenta

A commercial Cryptolepis product. Laboratory and animal evidence discussed here should not be confused with proven human treatment efficacy.

View Cryptolepis on Amazon
Amazon affiliate link
ArtemisininWhat I personally used

Artemisinin

A commercial Artemisinin product. Experimental evidence discussed here is mixed and does not establish commercial supplements as proven human babesiosis treatment.

View Artemisinin on Amazon
Amazon affiliate link
Amazon disclosure: As an Amazon Associate I earn from qualifying purchases. Buying through an affiliate link may earn Beat Babesia a commission at no additional cost to you.
Products I used + practical support

Products worth knowing about

Cryptolepis and artemisinin are the two products I personally used during my Babesia experience. I am sharing what I used, not prescribing a treatment. The other items are practical support products people may find useful while keeping track of medications, supplements, and hydration.

Cryptolepis sanguinolentaWhat I personally used

Cryptolepis sanguinolenta

The Cryptolepis product I personally used. See the Cryptolepis page for the research, limitations, and my experience.

View Cryptolepis on Amazon
Amazon affiliate link
ArtemisininWhat I personally used

Artemisinin

The artemisinin product I personally used. See the Artemisinin page for the research, limitations, and my experience.

View Artemisinin on Amazon
Amazon affiliate link
Sukuos large weekly AM PM pill organizerPractical support

Large weekly pill organizer

A simple way to keep prescriptions and supplements organized when a routine gets complicated.

View pill organizer on Amazon
Amazon affiliate link
Liquid I.V. Hydration Multiplier electrolyte drink mixPractical support

Hydration / electrolyte packets

Convenient hydration support for people who want an easy electrolyte option. This is not a Babesia treatment.

View hydration packets on Amazon
Amazon affiliate link
Amazon disclosure: As an Amazon Associate I earn from qualifying purchases. Buying through an affiliate link may earn Beat Babesia a commission at no additional cost to you.